STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Operating expenses:
Research and development	$ 22,471,496	$ 25,355,346
General & administrative	9,004,578	10,707,447
Total operating expenses	31,476,074	36,062,793
Operating loss	(31,476,074)	(36,062,793)
Gain on derivative instruments	0	366,791
Other non-operating losses	0	(30,793)
Interest expense, net	(675,416)	(1,081,034)
Other (expense) income	(42,813)	107,148
Net loss	(32,194,303)	(36,700,681)
Modification of warrants	(171,552)	(929,122)
Net loss available to common shareholders	$ (32,365,855)	$ (37,629,803)
Net loss per common share - basic and diluted	$ (0.73)	$ (0.87)
Weighted average common shares outstanding - basic and diluted	44,479,865	43,148,888